|
Miller, M (2009) Dyslipidemia and cardiovascular risk: the importance of early prevention. QJM 102:657-67
|
|
Tomita, N; Morishita, R; Tomita, S et al. (2000) Transcription factor decoy for NFkappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo. Gene Ther 7:1326-32
|
|
Pratt, R E (1999) Angiotensin II and the control of cardiovascular structure. J Am Soc Nephrol 10 Suppl 11:S120-8
|
|
Hutchinson, H G; Hein, L; Fujinaga, M et al. (1999) Modulation of vascular development and injury by angiotensin II. Cardiovasc Res 41:689-700
|
|
Pratt, R E; Dzau, V J (1999) Genomics and hypertension: concepts, potentials, and opportunities. Hypertension 33:238-47
|
|
Wu, C F; Bishopric, N H; Pratt, R E (1997) Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J Biol Chem 272:14860-6
|
|
Dzau, V J; Gibbons, G H; Mann, M et al. (1997) Future horizons in cardiovascular molecular therapeutics. Am J Cardiol 80:33I-39I
|
|
Hutchinson, H G; Trindade, P T; Cunanan, D B et al. (1997) Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells. Cardiovasc Res 35:158-67
|
|
Hein, L; Stevens, M E; Barsh, G S et al. (1997) Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc Natl Acad Sci U S A 94:6391-6
|
|
Zhang, J; Pratt, R E (1996) The AT2 receptor selectively associates with Gialpha2 and Gialpha3 in the rat fetus. J Biol Chem 271:15026-33
|
Showing the most recent 10 out of 50 publications
